Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at pegylated interferon for polycythaemia vera and essential thrombocythaemia (Pegasys)

Overview

Cancer types:

Blood cancers, Polycythaemia, Thrombocythaemia

Status:

Results

Phase:

Phase 3

Details

This trial compared a pegylated interferon with hydroxyurea. It was for polycythaemia vera and essential thrombocythaemia.

The trial was supported by Cancer Research UK. It was open for people to join between 2011 and 2016. The research team published the results in 2022.

Recruitment start: 1 September 2011

Recruitment end: 30 June 2016

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Claire Harrison

Supported by

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

Guy's and St Thomas' NHS Foundation Trust

Mario Negri (IRCCS)

Myeloproliferative Disorders Research Consortium (USA)

NIHR Clinical Research Network: Cancer

Roche

Other information

This is Cancer Research UK trial number CRUK/11/048.

Last reviewed: 29 November 2022

CRUK internal database number: 8124

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.